Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $121K invested in Kazia Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0.01% less ownership
Funds ownership: 0.01% → 0.01% (-0.01%)
10% less funds holding
Funds holding: 10 → 9 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
79% less capital invested
Capital invested by funds: $569K → $121K (-$448K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$1.57K |
| 2 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$1.18K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$160K |
| 2 |
Morgan Stanley
New York
|
-$41.5K |
| 3 |
JP Morgan Chase
New York
|
-$12.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.49K |
| 5 |
Citigroup
New York
|
-$1.27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $93.9K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $20.6K | -$1.49K | -252 | -5% |
|
|
MCM
3
MAI Capital Management
Independence,
Ohio
| $3.02K | -$160K | -27,071 | -97% |
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $1.49K | -$1.03K | -174 | -31% |
|
|
GI
5
GAMMA Investing
Foster City,
California
| $1.04K | +$1.57K | +265 | New |
|
|
AAP
6
Arax Advisory Partners
Denver,
Colorado
| $783 | +$1.18K | +200 | New |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $39 | – | – | – |
|
|
AF
8
Allworth Financial
Folsom,
California
| $4 | -$12 | -2 | Closed |
|
|
9
Wells Fargo
San Francisco,
California
| $3 | +$6 | +1 | New |
|
|
10
Morgan Stanley
New York
| – | -$41.5K | -4,688 | Closed |
|
|
11
JP Morgan Chase
New York
| – | -$12.8K | -1,441 | Closed |
|
|
12
Citigroup
New York
| – | -$1.27K | -144 | Closed |
|
13
Simplex Trading
Chicago,
Illinois
| – | -$834 | -141 | -99% |
|
KZIA Hedge Fund Activity: Q1 2025 in Review
9 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2025, worth a combined $121K — down 79% from $569K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of KZIA and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest buyer was GAMMA Investing, opening a new position worth an estimated $1.57K. The largest seller was MAI Capital Management, cutting an estimated $160K.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2025, down from 10 in Q4 2024.
- Funds reported $121K of Kazia Therapeutics stock for Q1 2025, down 79% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q1 2025 and 4 closed out, a net change of -1 holder.
- The largest Kazia Therapeutics buyer in Q1 2025 was GAMMA Investing, an estimated $1.57K added.
- The largest Kazia Therapeutics seller in Q1 2025 was MAI Capital Management, an estimated $160K sold.
Based on aggregated 13F filings for Q1 2025.